WO2014170842A3 - Utilisation de dérivés d'acides carboxyliques d'alkyle substitués comme agonistes du grp - Google Patents
Utilisation de dérivés d'acides carboxyliques d'alkyle substitués comme agonistes du grp Download PDFInfo
- Publication number
- WO2014170842A3 WO2014170842A3 PCT/IB2014/060763 IB2014060763W WO2014170842A3 WO 2014170842 A3 WO2014170842 A3 WO 2014170842A3 IB 2014060763 W IB2014060763 W IB 2014060763W WO 2014170842 A3 WO2014170842 A3 WO 2014170842A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carboxylic acid
- substituted alkyl
- acid derivatives
- alkyl carboxylic
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D305/08—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention concerne des dérivés d'acides carboxyliques d'alkyle substitués (composés de formule (I)), leurs procédés de préparation, des compositions pharmaceutiques contenant lesdits composés, leur utilisation comme agonistes du GPR (récepteur de la protéine G), en particulier comme agonistes du GPR40, et des méthodes d'utilisation de ces composés pour le traitement de maladies ou d'affections dans lesquelles intervient le GPR40.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361812784P | 2013-04-17 | 2013-04-17 | |
US61/812,784 | 2013-04-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014170842A2 WO2014170842A2 (fr) | 2014-10-23 |
WO2014170842A3 true WO2014170842A3 (fr) | 2015-02-19 |
Family
ID=50685997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2014/060763 WO2014170842A2 (fr) | 2013-04-17 | 2014-04-16 | Utilisation de dérivés d'acides carboxyliques d'alkyle substitués comme agonistes du grp |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR096041A1 (fr) |
TW (1) | TW201534593A (fr) |
WO (1) | WO2014170842A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105566267A (zh) * | 2016-01-27 | 2016-05-11 | 中国药科大学 | 一类新型肟醚衍生物、其制备方法及其作为药物的用途 |
KR102586510B1 (ko) | 2018-02-13 | 2023-10-12 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
WO2019204609A1 (fr) | 2018-04-19 | 2019-10-24 | Gilead Sciences, Inc. | Inhibiteurs pd-1/pd-l1 |
PT3820572T (pt) | 2018-07-13 | 2023-11-10 | Gilead Sciences Inc | Inibidores pd-1/pd-l1 |
JP7158577B2 (ja) | 2018-10-24 | 2022-10-21 | ギリアード サイエンシーズ, インコーポレイテッド | Pd-1/pd-l1阻害剤 |
AU2020363377A1 (en) | 2019-10-07 | 2022-04-21 | Kallyope, Inc. | GPR119 agonists |
BR112022023359A2 (pt) | 2020-05-19 | 2023-04-18 | Kallyope Inc | Ativadores de ampk |
CN116390925A (zh) | 2020-06-26 | 2023-07-04 | 卡尔优普公司 | Ampk活化剂 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008001931A2 (fr) * | 2006-06-27 | 2008-01-03 | Takeda Pharmaceutical Company Limited | Composés cycliques condensés |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1737809B1 (fr) | 2004-02-27 | 2013-09-18 | Amgen, Inc | Composes, compositions pharmaceutiques et procedes d'utilisation dans le traitement de troubles metaboliques |
JP2011515341A (ja) | 2008-03-06 | 2011-05-19 | アムジエン・インコーポレーテツド | 代謝障害の治療に有用な立体配座的に制限されたカルボン酸誘導体 |
CA2739888C (fr) | 2008-10-15 | 2013-11-19 | Amgen Inc. | Modulateurs spirocycliques de gpr40 |
TW201103535A (en) | 2009-04-22 | 2011-02-01 | Astellas Pharma Inc | Carboxylic acid compounds |
BR112013001571A2 (pt) | 2010-07-23 | 2016-05-10 | Connexios Life Sciences Pvt Ltd | composto, composição farmacêutica, uso e método de prevenção ou tratamento de uma condição associada com a função do receptor gpr40 |
-
2014
- 2014-04-16 WO PCT/IB2014/060763 patent/WO2014170842A2/fr active Application Filing
- 2014-04-16 AR ARP140101621A patent/AR096041A1/es unknown
- 2014-04-17 TW TW103114044A patent/TW201534593A/zh unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008001931A2 (fr) * | 2006-06-27 | 2008-01-03 | Takeda Pharmaceutical Company Limited | Composés cycliques condensés |
Also Published As
Publication number | Publication date |
---|---|
TW201534593A (zh) | 2015-09-16 |
WO2014170842A2 (fr) | 2014-10-23 |
AR096041A1 (es) | 2015-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014170842A3 (fr) | Utilisation de dérivés d'acides carboxyliques d'alkyle substitués comme agonistes du grp | |
PH12017500941A1 (en) | Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof | |
MY192717A (en) | Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof | |
EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
EA201501122A1 (ru) | Новые агонисты соматостатиновых рецепторов подтипа 4 (sstr4) | |
WO2014028589A3 (fr) | Composés d'acide benzoïque substitués par un 4-hétéroaryle à titre d'inhibiteurs de rorgammat et leurs utilisations | |
GEP201706671B (en) | Heterocyclyl compounds as mek inhibitors | |
EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
JO3781B1 (ar) | مشتقات الكينولون | |
MX363127B (es) | Derivados de benzotiofeno como inhibidores del receptor de estrogeno. | |
NZ729037A (en) | Carboxylic acid compound, method for preparation thereof, and use thereof | |
PH12016500885A1 (en) | Novel heterocyclic compounds | |
PH12016500394A1 (en) | Polymorphic form of pyrrole derivative and intermediate thereof | |
IN2014MN00697A (fr) | ||
MX340983B (es) | Composiciones farmaceuticas y nutraceuticas de acido abscisico. | |
PH12014501195A1 (en) | Novel 2h-indazoles as ep2, receptor antagonists | |
CA2922375C (fr) | Formes de sels d'alpha-tea: compositions et utilisations therapeutiques | |
CY1120744T1 (el) | Παραγωγα οξικου οξεος αζαϊνδολης και η χρηση αυτων ως ρυθμιστων υποδοχεων προσταγλανδινης d2 | |
WO2014159061A3 (fr) | Dérivés hétérocycliques à condensation benzo utiles en tant qu'agonistes de gpr120 | |
MY192609A (en) | Substituted bicyclic heteroaryl compounds as rxr agonists | |
EA201790522A1 (ru) | Соль производного цефалоспорина, ее кристаллическое твердое вещество и способ ее получения | |
MX2016011900A (es) | Derivados de acido azaindol-acetico y su uso como moduladores del receptor de prostaglandina d2. | |
MX351994B (es) | Formas cristalinas de [(s)-1-carbamoil-2-(feniil-pirimidin-2-il-am ino)-etil]-amida del acido 2-(2-metilamino-pirimidin-4-il)-1h-indo l-5-carboxilico. | |
WO2015001565A3 (fr) | "procédé amélioré pour la préparation de 3-aryloxy-3- phénylpropylamine et son sel" | |
EA201590452A1 (ru) | СОЛИ СОЕДИНЕНИЯ БЕНЗОТИАЗОЛОНА В КАЧЕСТВЕ АГОНИСТОВ β-2-АДРЕНОРЕЦЕПТОРОВ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14722771 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14722771 Country of ref document: EP Kind code of ref document: A2 |